Remote monitoring of cardiovascular implantable electronic devices provides real-time physiologic parameters that can potentially identify patients at high risk of heart failure deterioration.
Does remote monitoring of cardiovascular implantable electronic devices (CIEDs) prevent hospitalizations in patients with heart failure?
Remote monitoring of CIEDs provides real-time physiologic parameters that may help identify HF patients at high risk of deterioration, potentially preventing hospitalizations.
Despite recent developments, heart failure (HF) remains to be a great burden to the individual patient, entailing major morbidity and mortality. Moreover, HF is a great burden to overall healthcare, mainly because of frequent hospitalizations. Timely diagnosis of HF deterioration and implementation of appropriate therapy may prevent hospitalization and eventually improve a patient's prognosis; however, depending on the patient's presentation, the signs and symptoms of HF often offer too little therapeutic window to prevent hospitalizations. Cardiovascular implantable electronic devices (CIEDs) can provide real-time physiologic parameters and remote monitoring of these parameters can potentially help to identify patients at high risk. However, routine implementation of remote monitoring of CIEDs has still not been widely used in daily patient care. This review gives a detailed description of available metrics for remote HF monitoring, the studies that provide evidence of their efficacy, ways to implement them in clinical HF practice, as well as lessons learned on where to go on from where we currently are.
Assa et al. (Fri,) conducted a review in Heart failure. Remote monitoring of cardiovascular implantable electronic devices (CIEDs) was evaluated. Remote monitoring of cardiovascular implantable electronic devices provides real-time physiologic parameters that can potentially identify patients at high risk of heart failure deterioration.